D M Harrison1, X Li2, H Liu3, C K Jones2, B Caffo4, P A Calabresi5, P van Zijl2. 1. From the Department of Neurology (D.M.H.), University of Maryland School of Medicine, Baltimore, Maryland Departments of Neurology (D.M.H., P.A.C.) dharrison@som.umaryland.edu. 2. Radiology and Radiological Science (X.L., C.K.J., P.v.Z.) F.M. Kirby Research Center for Functional Brain Imaging (X.L., H.L., C.K.J., P.v.Z.), Kennedy Krieger Institute, Baltimore, Maryland. 3. F.M. Kirby Research Center for Functional Brain Imaging (X.L., H.L., C.K.J., P.v.Z.), Kennedy Krieger Institute, Baltimore, Maryland Department of Radiology (H.L.), Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangzhou, China. 4. Biostatistics (B.C.), Johns Hopkins University School of Medicine, Baltimore, Maryland. 5. Departments of Neurology (D.M.H., P.A.C.).
Abstract
BACKGROUND AND PURPOSE: Susceptibility MR imaging contrast variations reflect alterations in brain iron and myelin content, making this imaging tool relevant to studies of multiple sclerosis lesion heterogeneity. In this study, we aimed to characterize the relationship of high-field, susceptibility contrasts in multiple sclerosis lesions to clinical outcomes. MATERIALS AND METHODS: Twenty-four subjects with multiple sclerosis underwent 7T MR imaging of the brain, disability examinations, and a fatigue inventory. The inverse of T2* relaxation time (R2*), frequency, and relative susceptibility (from quantitative susceptibility mapping) were analyzed in 306 white matter lesions. RESULTS: Most lesions were hypointense on R2* (88% without a rim, 5% with). Lesions that were hyperintense on quantitative susceptibility mapping were more frequent in relapsing-remitting than in progressive multiple sclerosis (54% versus 35%, P = .018). Hyperintense lesion rims on quantitative susceptibility maps were more common in progressive multiple sclerosis and patients with higher levels of disability and fatigue. Mean lesion R2* was inversely related to disability and fatigue and significantly reduced in progressive multiple sclerosis. Relative susceptibility was lower in lesions in progressive multiple sclerosis (median, -0.018 ppm; range, -0.070 to 0.022) than in relapsing-remitting MS (median, -0.010 ppm; range, -0.062 to 0.052; P = .003). CONCLUSIONS: A progressive clinical phenotype and greater disability and fatigue were associated with lower R2* and relative susceptibility values (suggestive of low iron due to oligodendrocyte loss) and rimmed lesions (suggestive of chronic inflammation) in this multiple sclerosis cohort. Lesion heterogeneity on susceptibility MR imaging may help explain disability in multiple sclerosis and provide a window into the processes of demyelination, oligodendrocyte loss, and chronic lesion inflammation.
BACKGROUND AND PURPOSE: Susceptibility MR imaging contrast variations reflect alterations in brain iron and myelin content, making this imaging tool relevant to studies of multiple sclerosis lesion heterogeneity. In this study, we aimed to characterize the relationship of high-field, susceptibility contrasts in multiple sclerosis lesions to clinical outcomes. MATERIALS AND METHODS: Twenty-four subjects with multiple sclerosis underwent 7T MR imaging of the brain, disability examinations, and a fatigue inventory. The inverse of T2* relaxation time (R2*), frequency, and relative susceptibility (from quantitative susceptibility mapping) were analyzed in 306 white matter lesions. RESULTS: Most lesions were hypointense on R2* (88% without a rim, 5% with). Lesions that were hyperintense on quantitative susceptibility mapping were more frequent in relapsing-remitting than in progressive multiple sclerosis (54% versus 35%, P = .018). Hyperintense lesion rims on quantitative susceptibility maps were more common in progressive multiple sclerosis and patients with higher levels of disability and fatigue. Mean lesion R2* was inversely related to disability and fatigue and significantly reduced in progressive multiple sclerosis. Relative susceptibility was lower in lesions in progressive multiple sclerosis (median, -0.018 ppm; range, -0.070 to 0.022) than in relapsing-remitting MS (median, -0.010 ppm; range, -0.062 to 0.052; P = .003). CONCLUSIONS: A progressive clinical phenotype and greater disability and fatigue were associated with lower R2* and relative susceptibility values (suggestive of low iron due to oligodendrocyte loss) and rimmed lesions (suggestive of chronic inflammation) in this multiple sclerosis cohort. Lesion heterogeneity on susceptibility MR imaging may help explain disability in multiple sclerosis and provide a window into the processes of demyelination, oligodendrocyte loss, and chronic lesion inflammation.
Authors: Kathryn E Hammond; Meredith Metcalf; Lucas Carvajal; Darin T Okuda; Radhika Srinivasan; Dan Vigneron; Sarah J Nelson; Daniel Pelletier Journal: Ann Neurol Date: 2008-12 Impact factor: 10.422
Authors: Xu Li; Daniel M Harrison; Hongjun Liu; Craig K Jones; Jiwon Oh; Peter A Calabresi; Peter C M van Zijl Journal: J Magn Reson Imaging Date: 2015-06-14 Impact factor: 4.813
Authors: Bing Yao; Francesca Bagnato; Eiji Matsuura; Hellmut Merkle; Peter van Gelderen; Fredric K Cantor; Jeff H Duyn Journal: Radiology Date: 2011-11-14 Impact factor: 11.105
Authors: Martina Absinta; Pascal Sati; María I Gaitán; Pietro Maggi; Irene C M Cortese; Massimo Filippi; Daniel S Reich Journal: Ann Neurol Date: 2013-09-16 Impact factor: 10.422
Authors: Ulrike W Kaunzner; Yeona Kang; Shun Zhang; Eric Morris; Yihao Yao; Sneha Pandya; Sandra M Hurtado Rua; Calvin Park; Kelly M Gillen; Thanh D Nguyen; Yi Wang; David Pitt; Susan A Gauthier Journal: Brain Date: 2019-01-01 Impact factor: 13.501
Authors: Yi Wang; Pascal Spincemaille; Zhe Liu; Alexey Dimov; Kofi Deh; Jianqi Li; Yan Zhang; Yihao Yao; Kelly M Gillen; Alan H Wilman; Ajay Gupta; Apostolos John Tsiouris; Ilhami Kovanlikaya; Gloria Chia-Yi Chiang; Jonathan W Weinsaft; Lawrence Tanenbaum; Weiwei Chen; Wenzhen Zhu; Shixin Chang; Min Lou; Brian H Kopell; Michael G Kaplitt; David Devos; Toshinori Hirai; Xuemei Huang; Yukunori Korogi; Alexander Shtilbans; Geon-Ho Jahng; Daniel Pelletier; Susan A Gauthier; David Pitt; Ashley I Bush; Gary M Brittenham; Martin R Prince Journal: J Magn Reson Imaging Date: 2017-03-10 Impact factor: 4.813
Authors: M A Clarke; D Pareto; L Pessini-Ferreira; G Arrambide; M Alberich; F Crescenzo; S Cappelle; M Tintoré; J Sastre-Garriga; C Auger; X Montalban; N Evangelou; À Rovira Journal: AJNR Am J Neuroradiol Date: 2020-05-21 Impact factor: 3.825
Authors: Junghun Cho; Thanh D Nguyen; Weiyuan Huang; Elizabeth M Sweeney; Xianfu Luo; Ilhami Kovanlikaya; Shun Zhang; Kelly M Gillen; Pascal Spincemaille; Ajay Gupta; Susan A Gauthier; Yi Wang Journal: J Cereb Blood Flow Metab Date: 2021-09-24 Impact factor: 6.960
Authors: Y Yao; T D Nguyen; S Pandya; Y Zhang; S Hurtado Rúa; I Kovanlikaya; A Kuceyeski; Z Liu; Y Wang; S A Gauthier Journal: AJNR Am J Neuroradiol Date: 2017-12-14 Impact factor: 3.825